Visbiome is the MOST STUDIED multi-strain probiotic available
Visbiome's unique proprietary formulation has been the subject of OVER 100 Clinical Studies since its invention in the late 90s.

-
Gastroenterology 119(2):305-309(2000)
-
Gastroenterology 124(5):1202-09(2003)
-
Gut 53(1):108-114(2004)
-
Inflamm Bowel Dis 14(5):662-668(2008)
-
Am J Gastroenterol 100(7):1539-46(2005)
-
Inflamm Bowel Dis 20:1562-1567(2014)
-
Med Sci Monit 10(11):PI126-131(2004)
-
Inflamm Bowel Dis 15(5):760-768(2009)
-
Clin Gastroenterol Hepatol 7(11):1202-9(2009)
-
Am J Gastroenterol 105(10):2218-27(2010)
-
Korean J Gastroenterol 60(2):94-101(2012)
-
Inflamm Bowel Dis 16(8):1286-98(2010)
-
Am J Gastroenterology 104(2):437-443(2009)
-
Alim Pharmacol Ther 17(7):895-904(2003)
-
Neurogastroenterol Motil 17(5):1-10(2005)
-
J Pediatr Gastroenterol Nutr 51(1):24-34(2010)
-
Res Microbiol 152(8):735-741(2001)
-
J Neurogastroenterol Motil 21(1):111-20(2015)
-
Probiotics & Antimicro. Prot. 3(1):1-7(2011)
-
Dig Dis Sci 60(1):186-94(2015)
-
Best Pract Res Clin Gastroenterol 16(1):77-90(2002)
-
Gastroenterology 124(6):1636-1650(2003)
-
Am J Gastroenterol 105(3):501-23(2010)
-
Z Gastroenterol 42(9):979-983(2004)
-
Gut 60(5):571-607(2011)
-
J. Crohns Colitis 2:63-92(2008)
-
Cochrane Database of Systematic Reviews (6). Art. No.: CD001176. DOI:10.1002/14651858.CD001176.pub2(2010)
-
World J Gastroenterol 13(6):912-915(2007)
-
Gastroenterology 147(6):1327-1337(2014)